Treatments › Diabetes & Hypertension with Kidney Disease
Diabetes & Hypertension with Kidney Disease
Managing the intersection of diabetes, high blood pressure, and kidney complications
Overview
Diabetes and hypertension are the two leading causes of kidney disease worldwide, often occurring together and accelerating kidney damage through diabetic nephropathy and hypertensive nephrosclerosis. Dr. Rajesh Goel provides comprehensive management of patients with both diabetes and hypertension-related kidney complications, using an integrated approach that addresses blood sugar control, blood pressure management, and kidney protection strategies. His treatment plans incorporate the latest evidence-based therapies including ACE inhibitors, ARBs, and SGLT2 inhibitors to slow disease progression.
Symptoms & Signs
- Increased protein in urine
- Swelling
- Fatigue
- Frequent urination (especially at night)
- Blurred vision
- Headaches
- Difficulty concentrating
Causes & Risk Factors
- Uncontrolled diabetes (prolonged high blood sugar)
- Uncontrolled hypertension
- Smoking
- Obesity
- Family history
- High-salt diet
Treatment Options
- Blood Pressure Management
- Blood Sugar Control (insulin/oral meds)
- Kidney Protection Strategies (ACE inhibitors/ARBs)
- SGLT2 inhibitors
- Dietary counseling
- Regular monitoring
Diagnosis
- HbA1c levels
- Urine albumin-to-creatinine ratio
- eGFR monitoring
- Blood pressure monitoring
- Fundoscopy
- Lipid profile
Prevention & Tips
- Strict blood sugar control (HbA1c < 7%)
- Blood pressure < 130/80 mmHg
- Low-salt diet
- Regular exercise
- Weight management
- Annual kidney function tests
- Quit smoking
Frequently Asked Questions
Not always, but uncontrolled diabetes over many years significantly increases the risk. Tight blood sugar and blood pressure control can prevent or delay diabetic kidney disease. Regular kidney function tests are essential for diabetic patients.
For most kidney disease patients, the target is below 130/80 mmHg. ACE inhibitors or ARBs are first-line medications as they provide additional kidney protection beyond blood pressure control.
SGLT2 inhibitors (like empagliflozin, dapagliflozin) are diabetes medications that have been shown to significantly slow kidney disease progression, even in non-diabetic patients. They are now a cornerstone of CKD treatment.
Need Help with Diabetes & Hypertension with Kidney Disease?
Schedule a consultation with Dr. Rajesh Goel for expert kidney care and personalized treatment.